The James Whale Fund petitioned SMC on behalf of patients for a better use of Sunitinib (Sutent)

The petition can be download as a PDF (see right)

The SMC responded as follows. Its final advice referred to in the letter from Robert Sanders can be downloaded as a PDF
(see right).

Dear Stephen, 

Thank you for your recent Patient Interest Group submission to the Scottish Medicines Consortium regarding sunitinib (Sutent). Please find attached the final advice.

Many thanks for your continued interest in SMC and its submission process.

Best wishes,
Robert

Robert Sanders
SMC Administrator
Scottish Medicines Consortium
NHS Quality Improvement Scotland
Delta House
50 West Nile Street
Glasgow G1 2NP